CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 3 filers reported holding CTI BIOPHARMA CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $25,022,466 | -25.3% | 5,957,730 | +6.9% | 0.00% | 0.0% |
| Q4 2022 | $33,484,180 | +20.2% | 5,571,411 | +16.4% | 0.00% | 0.0% |
| Q3 2022 | $27,854,000 | +6.6% | 4,786,023 | +9.4% | 0.00% | 0.0% |
| Q2 2022 | $26,128,000 | +55.4% | 4,376,439 | +21.6% | 0.00% | – |
| Q1 2022 | $16,810,000 | +101.1% | 3,599,415 | +6.8% | 0.00% | – |
| Q4 2021 | $8,359,000 | -22.9% | 3,370,815 | -8.3% | 0.00% | – |
| Q3 2021 | $10,844,000 | +18.3% | 3,676,004 | +0.3% | 0.00% | – |
| Q2 2021 | $9,165,000 | +3.4% | 3,666,204 | +20.4% | 0.00% | – |
| Q1 2021 | $8,862,000 | -7.1% | 3,045,312 | +2.8% | 0.00% | – |
| Q4 2020 | $9,538,000 | +56.4% | 2,962,312 | +4.4% | 0.00% | – |
| Q3 2020 | $6,098,000 | +144.7% | 2,836,130 | +32.0% | 0.00% | – |
| Q2 2020 | $2,492,000 | +26.0% | 2,149,048 | 0.0% | 0.00% | – |
| Q1 2020 | $1,977,000 | -17.5% | 2,149,048 | +41.8% | 0.00% | – |
| Q4 2019 | $2,395,000 | +115.2% | 1,515,674 | +13.4% | 0.00% | – |
| Q3 2019 | $1,113,000 | +22.7% | 1,336,805 | +26.6% | 0.00% | – |
| Q2 2019 | $907,000 | -37.9% | 1,055,954 | -29.8% | 0.00% | – |
| Q1 2019 | $1,460,000 | +32.5% | 1,504,296 | +0.1% | 0.00% | – |
| Q4 2018 | $1,102,000 | -78.6% | 1,502,494 | -37.1% | 0.00% | – |
| Q3 2018 | $5,158,000 | -56.6% | 2,387,830 | -0.0% | 0.00% | – |
| Q2 2018 | $11,896,000 | +41.7% | 2,388,851 | +11.0% | 0.00% | – |
| Q1 2018 | $8,396,000 | +268.2% | 2,152,864 | +153.0% | 0.00% | – |
| Q4 2017 | $2,280,000 | -33.6% | 850,881 | -20.9% | 0.00% | – |
| Q3 2017 | $3,433,000 | +37.7% | 1,076,049 | +42.8% | 0.00% | – |
| Q2 2017 | $2,494,000 | -26.9% | 753,379 | -7.3% | 0.00% | – |
| Q1 2017 | $3,412,000 | – | 812,498 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,904,400 | $3,355,000 | 2.31% |
| BVF INC/IL | 6,929,690 | $5,955,000 | 0.65% |
| CAXTON CORP | 324,452 | $279,000 | 0.32% |
| NEA Management Company, LLC | 3,750,000 | $3,222,000 | 0.23% |
| Orbimed Advisors | 5,000,000 | $4,297,000 | 0.07% |
| Fosun International Ltd | 459,274 | $390,000 | 0.03% |
| Paloma Partners Management Co | 229,800 | $197,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 127,602 | $110,000 | 0.00% |
| LMR Partners LLP | 54,931 | $47,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 17,495 | $15,000 | 0.00% |